Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment

Name: Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
Published: 2007
License: Public Domain

Neovii Biotech · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

breast-cancer drug-therapy immunotherapy

metastatic breast cancer, advanced breast cancer, breast cancer, investigational drug, drug therapy, antineoplastic protocols, immunotherapy, stage iii to iv breast cancer, hormonal therapy refractory, failure of hormonal therapy, her-2/neu expressing breast cancer, her-2/neu

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 911008
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.